Published in Cancer Weekly, March 30th, 2010
"The news surrounding our launch of OVA1™ last week and the announcement of the favorable Medicare coverage decision has placed increased demands on our time at the SGO meeting," said Gail S. Page, Vermillion's Chief Executive Officer. "The physicians attending this meeting are at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.